NL-OMON38092已完成不适用
Improved diagnosis of clinically occult breast lesions - IDO
niversitair Medisch Centrum Utrecht0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Female gender;
- •- Age >= 18 years;
- •- Nonpalpable mammographically suspicious breast lesion (classified as BIRADS 3-5) requiring stereotactic biopsy.
排除标准
- •- Legal incapability;
- •- Insufficient command of the Dutch language;
- •- Contraindication for temporarily stopping anticoagulant therapy;
- •- Inability to maintain a prone position for 1 hour;
- •- Ipsilateral breast implant;
- •- Lactation;
- •- Implanted electronic device;
研究者
相似试验
已完成
不适用
Detectability of breast lesions of dense breast using low-dose computed tomographyBreast lesionsJPRN-UMIN000029145Hokkaido University80
进行中（未招募）
不适用
ocalization of the sentinel node with microbubble contrast and Iodine-markersPatient with breast cancer with an indication for sentinel lymph node biopsyEUCTR2012-000333-40-NLniversity Medical Center Utrecht120
已完成
不适用
Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study)breast carcinoma1000629110006295breast cancerNL-OMON37670niversitair Medisch Centrum Utrecht120
进行中（未招募）
1 期
Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130
尚未招募
不适用
Biomarker detection for benign breast diseases and primary breast cancer by serum and tissue protein profiling.benign breast diseases10006291breast cancerNL-OMON30316Slotervaartziekenhuis380